Literature DB >> 18941937

Cerebral sinus venous thrombosis in a subject with thyrotoxicosis and MTHFR gene polymorphism.

Laura Strada1, Carlo Gandolfo, Massimo Del Sette.   

Abstract

We report a case of cerebral venous thrombosis (CVT) due to tyrotoxicosis in a patient with methylenetetrahydro-folate-reductase (MTHFR) gene polymorphism C677T, (genotype 677TT), in which discontinuation of intravenous heparin was followed by clinical and radiological worsening despite warfarin treatment. We discuss the relationship between CVT, MTHFR hyperthiroidism and anticoagulant therapy.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18941937     DOI： 10.1007/s10072-008-0992-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


  10 in total

1.  Thyrotoxicosis as a predisposing factor for cerebral venous thrombosis.

Authors:  H J Verberne; E Fliers; M F Prummel; J Stam; D P Brandjes; W M Wiersinga
Journal:  Thyroid       Date:  2000-07       Impact factor: 6.568

2.  Hyperthyroidism and cerebral venous thrombosis.

Authors:  S Mouton; N Nighoghossian; M Berruyer; L Derex; F Philippeau; S Cakmak; J Honnorat; M Hermier; P Trouillas
Journal:  Eur Neurol       Date:  2005-08-23       Impact factor: 1.710

3.  [Case of cerebral venous thrombosis due to graves' disease with increased factor VIII activity].

Authors:  Kensaku Kasuga; Satoshi Naruse; Maiko Umeda; Midori Tanaka; Nobuya Fujita
Journal:  Rinsho Shinkeigaku       Date:  2006-04

4.  EFNS guideline on the treatment of cerebral venous and sinus thrombosis.

Authors:  K Einhäupl; M-G Bousser; S F T M de Bruijn; J M Ferro; I Martinelli; F Masuhr; J Stam
Journal:  Eur J Neurol       Date:  2006-06       Impact factor: 6.089

Review 5.  [Thyroid crisis and protein C deficiency in a case of superior sagittal sinus thrombosis].

Authors:  Kiyomi Nagumo; Takeshi Fukushima; Hirokazu Takahashi; Yumi Sakakibara; Shigeyuki Kojima; Bunshiro Akikusa
Journal:  Brain Nerve       Date:  2007-03

Review 6.  Thyroid diseases and cerebrovascular disease.

Authors:  A Squizzato; V E A Gerdes; D P M Brandjes; H R Büller; J Stam
Journal:  Stroke       Date:  2005-09-22       Impact factor: 7.914

Review 7.  Heparin in the treatment of cerebral venous thrombosis.

Authors:  Saad Shafqat; Ayeesha K Kamal; Mohammad Wasay
Journal:  J Pak Med Assoc       Date:  2006-11       Impact factor: 0.781

8.  Phenotypic expression of the methylenetetrahydrofolate reductase 677C-->T polymorphism and flavin cofactor availability in thyroid dysfunction.

Authors:  Steinar Hustad; Bjørn G Nedrebø; Per Magne Ueland; Jørn Schneede; Stein Emil Vollset; Arve Ulvik; Ernst A Lien
Journal:  Am J Clin Nutr       Date:  2004-10       Impact factor: 7.045

9.  Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline.

Authors:  Ralph L Sacco; Robert Adams; Greg Albers; Mark J Alberts; Oscar Benavente; Karen Furie; Larry B Goldstein; Philip Gorelick; Jonathan Halperin; Robert Harbaugh; S Claiborne Johnston; Irene Katzan; Margaret Kelly-Hayes; Edgar J Kenton; Michael Marks; Lee H Schwamm; Thomas Tomsick
Journal:  Circulation       Date:  2006-03-14       Impact factor: 29.690

10.  Cerebral venous sinus thrombosis as a recurrent thrombotic event in a patient with heterozygous prothrombin G20210A genotype after discontinuation of oral anticoagulation therapy: how long should we treat these patients with warfarin?

Authors:  Ivana Jukic; Marina Titlic; Ante Tonkic; Daniel Rosenzweig
Journal:  J Thromb Thrombolysis       Date:  2007-01-24       Impact factor: 5.221
  10 in total
  2 in total

1.  Cerebral venous sinus thrombosis caused by traumatic brain injury complicating thyroid storm: a case report and discussion.

Authors:  Shurong Gong; Wenyao Hong; Jiafang Wu; Jinqing Xu; Jianxiang Zhao; Xiaoguang Zhang; Yuqing Liu; Rong-Guo Yu
Journal:  BMC Neurol       Date:  2022-07-07       Impact factor: 2.903

2.  Sinus sigmoideus thrombosis secondary to graves' disease: a case description.

Authors:  Ellen Hermans; Peter Mariën; Peter P De Deyn
Journal:  Case Rep Neurol       Date:  2011-09-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.